Searching. Please wait…
1583
37
170
29013
4402
2599
347
386
Abstract: The current outbreak of SARS-CoV-2 virus has caused a large increase in mortality and morbidity associated with respiratory diseases. Huge efforts are currently ongoing to develop a vaccine against this virus. However, alternative approaches could be considered in the fight against this disease. Among other strategies, structural-based drug design could be an effective approach to generate specific molecules against SARS-CoV-2, thus reducing viral burden in infected patients. Here, in addition to this structural approach, we also revise several therapeutic strategies to fight against this viral threat. Furthermore, we report ACE-2 genetic polymorphic variants affecting residues involved in close contacts with SARS-CoV-2 that might be associated to different infection risks. These analyses could provide valuable information to predict the course of the disease.
Authorship: Cabezón E., Arechaga I.,
Fuente: Frontiers in molecular biosciences 2020; 7: 204
Publisher: Frontiers Media
Year of publication: 2020
No. of pages: 11
Publication type: Article
DOI: 10.3389/fmolb.2020.00204
ISSN: 2296-889X
Publication Url: https//DOI: 10.3389/fmolb.2020.00204
Consult in UCrea Read publication
MARIA ELENA CABEZON NAVARRO
IGNACIO MARIA ARECHAGA ITURREGUI
Back